ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Supernus Pharmaceuticals 

1550 East Gude Drive

Rockville  Maryland  20850  U.S.A.
Phone: 301-838-2501 Fax: n/a


SEARCH JOBS



 Key Statistics


Email:
Ownership: Public

Web Site: Supernus Pharmaceuticals
Employees:
Symbol: SUPN
 



Industry
Pharmaceutical






 Company News
Supernus Pharmaceuticals (SUPN) Announces Fourth Quarter and Full Year 2013 Results 3/13/2014 9:25:16 AM    More...
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Third US Patent Protecting Trokendi XR™ 3/12/2014 9:32:24 AM    More...
Supernus Pharmaceuticals (SUPN) To Host Fourth Quarter And Full Year 2013 Earnings Conference Call 2/25/2014 7:54:15 AM    More...
Supernus Pharmaceuticals (SUPN) To Present At Cowen and Company Healthcare Conference In March 2/20/2014 7:23:01 AM    More...
Supernus Pharmaceuticals (SUPN) At Citibank And RBC Global Healthcare Conferences In February 2/7/2014 6:45:55 AM    More...
Supernus Pharmaceuticals (SUPN) Announces Publication Of Phase III Study (PROSPER) Results On Oxtellar XR® 2/3/2014 8:49:35 AM    More...
Supernus Pharmaceuticals (SUPN) Announces Issuance Of First Use Patents Protecting SPN-812 As A Novel Non-Stimulant ADHD Product 1/27/2014 8:51:05 AM    More...
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Third US Patent Protecting Oxtellar XR® 1/7/2014 9:30:27 AM    More...
Supernus Pharmaceuticals (SUPN) Announces Resignation Of Board Member 12/27/2013 7:28:03 AM    More...
Supernus Pharmaceuticals (SUPN) Announces FDA Approval Of Its Partner's Product, Orenitram™ 12/27/2013 6:49:28 AM    More...
123456